We’re sorry, we are currently experiencing some issues, please try again later. Our team is working diligently to resolve the issue. Thank you for your patience and ...
EMD Serono, the Healthcare business of Merck KGaA, Darmstadt, Germany, in the U.S. and Canada, today announced positive data on enpatoran, an investigational, oral, novel TLR7/8 inhibitor, ...
12d
EMD Serono Announces Healthcare Leadership Changes for Global Commercial Strategy and North America
EMD Serono, the Healthcare business of Merck KGaA, Darmstadt, Germany, in the U.S. and Canada, today announced that Miguel Fernández Alcalde has been appointed Head of Global Commercial Strategy.
ROCKLAND, Mass.--(BUSINESS WIRE)--EMD Serono, the Healthcare business sector of Merck KGaA, Darmstadt, Germany, in the U.S. and Canada, today announced enrollment has been completed in the Phase III ...
EMD Serono Inc., Merck KGaA’s North American drug development business, has officially taken up residence in Boston’s Seaport District. Gary Higgins / Boston ...
The $39-million investment is the largest investment the company has made in its semiconductor equipment and services business. Opening of the new factory is part of the company's strategy to expand ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results